# ReMedFiLM Publication Writing Guide (Version 6.0)

**Target Venues:** IEEE Transactions on Medical Imaging (TMI), Medical Image Analysis (MedIA)  
**Method:** ReMedFiLM (FULL RA-MedFiLM-BARR Modular System)  
**Internal Backbone / Comparator:** GlobalMedFiLM ($G$)  
**Status:** Canonical & Frozen  

---

## 1. Central Narrative Strategy

The primary narrative must focus on **Risk-Averse Modular Refinement in Multi-Domain Medical Imaging**:
1. **The Medical Challenge:** Medical image segmentation spans heterogeneous modalities with highly variable lesion scales, from macroscopic dermoscopy lesions to subtle, sub-centimeter urinary calculi on plain radiographs. Standard monolithic segmentation networks trained across multiple domains suffer from multi-task gradient interference or boundary blur.
2. **The Secondary Refinement Trap:** A natural intuition is to deploy a secondary high-capacity crop refiner. However, unconstrained secondary refinement is actively dangerous: on the development cohort, unconditional refinement (Arm A1) degraded segmentation accuracy in **42.7% of all cases**.
3. **The ReMedFiLM Solution:** ReMedFiLM solves this by composing:
   - A task-conditioned global encoder–decoder (**GlobalMedFiLM**, 3.52M params) providing prior masks without negative task interference.
   - A learned **Benefit Router ($B_\phi$)** evaluating expected paired gain against compute cost, skipping unpromising cases.
   - A dedicated **Regional Residual Refiner ($R_\psi$)** predicting residual boundary corrections on $256 \times 256$ crops.
   - A **Post-Safety Gate ($S_\omega$)** providing fail-closed fallback to the global prediction whenever divergence indicates hallucinatory artifacts.
4. **Key Empirical Triumph:** ReMedFiLM cuts the all-population harm rate from 42.7% to **7.87%**, while boosting paired Dice on ambiguous targets (+0.61 pp on KUB radiography, +0.28 pp macro development mean).

---

## 2. Mandatory Reporting Rules & Guardrails

### 2.1 Model Branding & Disambiguation
- **Rule 1:** Always refer to the proposed method as **ReMedFiLM** or **ReMedFiLM (FULL RA-MedFiLM-BARR)**.
- **Rule 2:** Never refer to **GlobalMedFiLM** as the proposed method. GlobalMedFiLM is the *internal global backbone* and the baseline comparator (Arm A0).
- **Rule 3:** The total parameter count of ReMedFiLM is **4,837,420 parameters** ($G$: 3,523,001 + $R_\psi$: 1,276,401 + $B_\phi$: 36,801 + $S_\omega$: 1,217). The integration harness adds 0 trainable parameters.

### 2.2 Statistical & Comparative Claims
- **Rule 4:** Do not claim universal statistical superiority over all baselines. On VAL808, GlobalMedFiLM and ReMedFiLM significantly outperform U-Net, Attention U-Net, U-Net++, and MiT-UNet ($p < 0.05$ via paired bootstrap), but the comparison against DeepLabV3+ includes zero in its 95% bootstrap interval ($[-0.007, +0.022]$). Frame the comparison as **computational efficiency**: ReMedFiLM achieves comparable/higher accuracy with **8.3x fewer parameters** (4.84M vs. 40.35M).
- **Rule 5:** Never cite unsupported $p < 10^{-4}$ values. Frame ReMedFiLM development results in terms of **paired non-inferiority preservation** (lower 95% bootstrap CI $> -0.005$) and empirical harm reduction.

### 2.3 Transparent Disclosure of Negative Findings
Reviewers at IEEE TMI / MedIA value rigorous scientific honesty. The manuscript must prominently highlight:
- **Stone-Free Control Radiographs:** On 14 normal radiographs without urinary stones, the model triggered false-positive predictions on **14 out of 14 cases** (Dice 0.000). The safety gate rejected 1 case but adopted 7 hallucinatory refinements. Position this as an open radiological challenge necessitating dedicated negative-case calibration losses in clinical practice.
- **Acquisition Noise Vulnerability:** Under Gaussian noise stress (std=0.10), performance on KUB radiographs collapsed by **-36.36 pp** (from 77.02% to 40.66%), while optical modalities remained robust.
- **Multi-Seed Backbone Sharing:** Disclose that historical seeds 42, 123, and 3407 evaluated router/refiner variation on a *shared pre-trained GlobalMedFiLM backbone*. Independent re-training of the global backbone remains an ongoing objective.
- **Pending Prospective Milestones:** Clearly state that formal causal attribution studies (C1 learned vs. frozen identity FiLM, C2 controlled component ablations, C3 24-cell matched matrix) are prospective milestones.

---

## 3. Recommended Manuscript Structure

1. **Title:** *ReMedFiLM: Task-Conditioned Global-to-Regional Medical Image Segmentation with Risk-Averse Refinement*
2. **Abstract:** Emphasize multi-domain generalization, the danger of unconstrained refinement (42.7% harm rate), the 4-component architecture, 4.84M parameter footprint, paired preservation (+0.28 pp dev mean), and transparent clinical limitations.
3. **Introduction:** Clinical motivation across 4 domains; the trade-off between global context and local resolution; the failure of naive secondary refinement.
4. **Methodology:** 
   - Section III-A: Task embedding and FiLM modulation in GlobalMedFiLM ($G$).
   - Section III-B: Benefit Router ($B_\phi$) utility gate ($U \ge \tau$).
   - Section III-C: Regional Refiner ($R_\psi$) logit residual correction.
   - Section III-D: Post-Safety Filter ($S_\omega$) fail-closed rollback.
   - Section III-E: Staged freeze training paradigm.
5. **Experimental Setup:** Four development domains (ISIC, BUSI, Kvasir, KUB, N=808); retrospective external cohorts (N=884); implementation and evaluation protocols.
6. **Results:**
   - Table 1 & Fig 3: Internal 7-model comparison on VAL808.
   - Table 2 & Fig 4: Domain-wise and subclass performance.
   - Fig 6–9: Semantic segmentation visual galleries with TP/FP/FN overlays.
   - Table 3 & Fig 15: 13-arm ablation and harm-reduction dynamics.
   - Table 4 & Fig 11–12: Retrospective external evaluation (CVC, BrEaST, Stones).
   - Fig 18–19: Robustness, Pareto frontier, and latency accounting.
7. **Discussion & Clinical Implications:** Harm mitigation vs. absolute gain; false positives on stone-free radiographs; acquisition noise sensitivity; limitations.
8. **Conclusion:** ReMedFiLM provides a reproducible, compute-efficient framework for reliable medical segmentation.
